Vossel K.A., Tartaglia M.C., Nygaard H.B., Zeman A.Z., Miller B.L. 2017. Epileptic activity in Alzheimer’s disease. Lancet Neurology. 16 (4), 311–322.
Chai Z., Ma C., Jin X. 2019. Homeostatic activity regulation as a mechanism underlying the effect of brain stimulation. Bioelectron Med. 5, 16.
Article PubMed PubMed Central Google Scholar
Turovsky E.A., Turovskaya M.V., Gaidin S.G., Zinchenko V.P. 2017. Cytokine IL-10, activators of PI3-kinase, agonists of α-2 adrenoreceptor and antioxidants prevent ischemia-induced cell death in rat hippocampal cultures. Archives Biochem. Biophys. 615 (1), 35–43.
Finnerup N.B., Attal N., Haroutounian S., McNicol E., Baron R., Dworkin R.H., Gilron I., Haanpää M., Hansson P., Jensen T.S., Kamerman P.R., Lund K., Moore A., Raja S.N., Rice A.S.C., Rowbotham M., Sena E., Siddall P., Smith B.H., Wallace M. 2015. Pharmacotherapy for neuropathic pain in adults. Lancet Neurology. 14 (2), 162–173.
Article CAS PubMed Google Scholar
Yoo J.Y., Panov F. 2019. Identification and treatment of drug-resistant epilepsy. Continuum (Minneap. Minn.). 25 (2), 362–380.
Wu J. 2019. Cannabis, cannabinoid receptors, and endocannabinoid system. Acta Pharmacol. Sin. 40 (3), 297–299.
Article CAS PubMed PubMed Central Google Scholar
Montero-Oleas N., Arevalo-Rodriguez I., Nuñez-González S., Viteri-García A., Simancas-Racines D. 2020. Therapeutic use of cannabis and cannabinoids: An evidence mapping and appraisal of systematic reviews. BMC Complement. Med. Ther. 20 (1), 2456.
Kow R.L., Jiang K., Naydenov A.V., Le J.H., Stella N., Nathanson N.M. 2014. Modulation of pilocarpine-induced seizures by cannabinoid receptor 1. PLoS One. 9 (4), e95922.
Article PubMed PubMed Central Google Scholar
Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutiérrez S.O., van der Stelt M., López-Rodriguez M.L., Casanova E., Schütz G., Zieglgänsberger W., Di Marzo V., Behl C., Lutz B. 2003. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science. 302 (5642), 84–88.
Article CAS PubMed Google Scholar
Zou S., Kumar U. 2018. Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system. Int. J. Mol. Sci. 19 (3), 833.
Article PubMed PubMed Central Google Scholar
Sagredo O., González S., Aroyo I., Pazos M.R., Benito C., Lastres-Becker I., Romero J.P., Tolón R.M., Mechoulam R., Brouillet E., Romero J., Fernández-Ruiz J. 2009. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity. Glia. 57 (11), 1154–1167.
Article PubMed PubMed Central Google Scholar
Chen D.-J., Gao M., Gao F.-F., Su Q.-X., Wu J. 2017. Brain cannabinoid receptor 2. Acta Pharmacol. Sin. 38 (3), 312–316.
Article CAS PubMed PubMed Central Google Scholar
Stempel A.V., Stumpf A., Zhang H.-Y., Özdoğan T., Pannasch U., Theis A.-K., Otte D.-M., Wojtalla A., Rácz I., Ponomarenko A., Xi Z.-X., Zimmer A., Schmitz D. 2016. Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus. Neuron. 90 (4), 795–809.
Article CAS PubMed PubMed Central Google Scholar
Stumpf A., Parthier D., Sammons R.P., Stempel A.V., Breustedt J., Rost B.R., Schmitz D. 2018. Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons. Neuropharmacology. 139, 217–225.
Article CAS PubMed Google Scholar
Ma Z., Gao F., Larsen B., Gao M., Luo Z., Chen D., Ma X., Qiu S., Zhou Y., Xie J., Xi Z.-X., Wu J. 2019. Mechanisms of cannabinoid CB2 receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area. EBioMedicine. 42, 225–237.
Article PubMed PubMed Central Google Scholar
Mason R., Cheer J.F. 2009. Cannabinoid receptor activation reverses kainate-induced synchronized population burst firing in rat hippocampus. Front. Integr. Neurosci. 3, 13.
PubMed PubMed Central Google Scholar
Milano W., Capasso A. 2018. Neuroprotection by cannabinoids in neurodegenerative diseases. Alzheimers Dement. Cogn. Neurol. 2 (1), 1–7.
Casillas-Espinosa P.M., Ali I., O’Brien T.J. 2020. Neurodegenerative pathways as targets for acquired epilepsy therapy development. Epilepsia Open. 5 (2), 138–154.
Article PubMed PubMed Central Google Scholar
Kendall D.A., Yudowski G.A. 2017. Cannabinoid receptors in the central nervous system. Front. Cell. Neurosci. 10, 9790.
Mitchell V.A., Jeong H.-J., Drew G.M., Vaughan C.W. 2011. Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray. Neuropsychopharmacology. 36 (9), 1801–1810.
Article CAS PubMed PubMed Central Google Scholar
Sánchez-Blázquez P., Rodríguez-Muñoz M., Garzón J. 2014. The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction. Front. Pharmacol. 4, 169.
Article PubMed PubMed Central Google Scholar
Navarrete M., Araque A. 2008. Endocannabinoids mediate neuron-astrocyte communication. Neuron. 57 (6), 883–893.
Article CAS PubMed Google Scholar
Bazargani N., Attwell D. 2016. Astrocyte calcium signaling. Nat. Neurosci. 19 (2), 182–189.
Article CAS PubMed Google Scholar
Navarrete M., Araque A. 2010. Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron. 68 (1), 113–126.
Article CAS PubMed Google Scholar
Hryhorowicz S., Kaczmarek-Ryś M., Andrzejewska A., Staszak K., Hryhorowicz M., Korcz A., Słomski R. 2019. Allosteric modulation of cannabinoid receptor 1—Current challenges and future opportunities. Int. J. Mol. Sci. 20 (23), 5874.
Article CAS PubMed PubMed Central Google Scholar
Bosoi C.R., Rose C.F. 2009. Identifying the direct effects of ammonia on the brain. Metab. Brain Dis. 24 (1), 95–102.
Article CAS PubMed Google Scholar
Dahlberg D., Ivanovic J., Hassel B. 2016. Toxic levels of ammonia in human brain abscess. J. Neurosurg. 124 (3), 854–860.
Article CAS PubMed Google Scholar
Dynnik V.V., Kononov A.V., Sergeev A.I., Teplov I.Y., Tankanag A.V., Zinchenko V.P., Abulseoud O.A. 2015. To break or to brake neuronal network accelerated by ammonium ions? PLoS ONE. 10 (7), e0134145.
Article PubMed PubMed Central Google Scholar
Gaidin S.G., Zinchenko V.P., Kosenkov A.M. 2020. Mechanisms of ammonium-induced neurotoxicity. Neuroprotective effect of alpha-2 adrenergic agonists. Archives Biochem. Biophys. 693, 108593.
Gaidin S.G., Zinchenko V.P., Sergeev A.I., Teplov I.Y., Mal’tseva V.N., Kosenkov A.M. 2020. Activation of alpha-2 adrenergic receptors stimulates GABA release by astrocytes. Glia. 68 (6), 1114–1130.
Zhu X., Birnbaumer L. 1996. G protein subunits and the stimulation of phospholipase C by Gs-and Gi-coupled receptors. Proc. Natl. Acad. Sci. USA. 93 (7), 2827–2831.
Article CAS PubMed PubMed Central Google Scholar
Madukwe J.C., Garland-Kuntz E.E., Lyon A.M., S-mrcka A.V. 2018. G protein βγ subunits directly interact with and activate phospholipase Cϵ. J. Biol. Chem. 293 (17), 6387–6397.
Article CAS PubMed PubMed Central Google Scholar
Enkvist M.O., Hämäläinen H., Jansson C.C., Kukkonen J.P., Hautala R., Courtney M.J., Akerman K.E. 1996. Coupling of astroglial alpha 2-adrenoreceptors to second messenger pathways. J. Neurochem. 66 (6), 2394–2401.
Article CAS PubMed Google Scholar
Ott P., Vilstrup H. 2014. Cerebral effects of ammonia in liver disease. Metab. Brain Dis. 29 (4), 901–911.
Article CAS PubMed Google Scholar
Huang Y., Thathiah A. 2015. Regulation of neuronal communication by G protein-coupled receptors. FEBS Lett. 589 (14), 1607–1619.
Article CAS PubMed Google Scholar
Wang T., Zhou G., He M., Xu Y., Rusyniak W.G., Xu Y., Ji Y., Simon R.P., Xiong Z.-G., Zha X.-M. 2020. GPR68 is a neuroprotective proton receptor in brain ischemia. Stroke. 51 (12), 3690–3700.
Article CAS PubMed PubMed Central Google Scholar
Poskanzer K.E., Yuste R. 2016. Astrocytes regulate cortical state switching in vivo. Proc. Natl. Acad. Sci. USA. 113 (19), E2675-84.
Comments (0)